Therapeutics For Attractive Markets With Unmet Medical Need


Home
Company
Technology
Targets
Jobs    
News
Contact

Clinical Trials












Imprint

date:
last Update:

deutsch


Clinical Trials
 

Alzheimer’s Disease
Two Alzheimer vaccines developed by Affiris, AFFITOPE AD01 and AFFITOPE AD02, have successfully passed the preclinical development phase and are entering the stage of clinical testing.

Information on AFFITOPE AD01/AFFiRiS 001

Information on AFFITOPE AD02/AFFiRiS 002


Atherosclerosis
In preparation

 



© AFFIRIS all rights reserved